Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial
Del Mastro, Lucia, Dr, De Placido, Sabino, Prof, Bruzzi, Paolo, MD, De Laurentiis, Michele, MD, Boni, Corrado, MD, Cavazzini, Giovanna, MD, Durando, Antonio, MD, Turletti, Anna, MD, Nisticò, Cecilia, MD, Valle, Enrichetta, MD, Garrone, Ornella, MD, Puglisi, Fabio, MD, Montemurro, Filippo, MD, Barni, Sandro, MD, Ardizzoni, Andrea, MD, Gamucci, Teresa, MD, Colantuoni, Giuseppe, MD, Giuliano, Mario, MD, Gravina, Adriano, MD, Papaldo, Paola, MD, Bighin, Claudia, MD, Bisagni, Giancarlo, MD, Forestieri, Valeria, MD, Cognetti, Francesco, MD
Published in The Lancet (British edition) (09.05.2015)
Published in The Lancet (British edition) (09.05.2015)
Get full text
Journal Article
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer
Puglisi, Fabio, Gerratana, Lorenzo, Lambertini, Matteo, Ceppi, Marcello, Boni, Luca, Montemurro, Filippo, Russo, Stefania, Bighin, Claudia, De Laurentiis, Michelino, Giuliano, Mario, Bisagni, Giancarlo, Durando, Antonio, Turletti, Anna, Garrone, Ornella, Ardizzoni, Andrea, Gamucci, Teresa, Colantuoni, Giuseppe, Gravina, Adriano, De Placido, Sabino, Cognetti, Francesco, Del Mastro, Lucia
Published in NPJ breast cancer (28.06.2021)
Published in NPJ breast cancer (28.06.2021)
Get full text
Journal Article
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial
Conte, PierFranco, Bisagni, Giancarlo, Piacentini, Federico, Sarti, Samanta, Minichillo, Santino, Anselmi, Elisa, Aieta, Michele, Gebbia, Vittorio, Schirone, Alessio, Musolino, Antonino, Garrone, Ornella, Beano, Alessandra, Rimanti, Anita, Giotta, Francesco, Turletti, Anna, Miglietta, Federica, Dieci, Maria Vittoria, Vicini, Roberto, Balduzzi, Sara, D'Amico, Robert, Guarneri, Valentina
Published in Journal of clinical oncology (10.11.2023)
Published in Journal of clinical oncology (10.11.2023)
Get full text
Journal Article
SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 Trials
Conte, Benedetta, Boni, Luca, Bisagni, Giancarlo, Durando, Antonio, Sanna, Giovanni, Gori, Stefania, Garrone, Ornella, Tamberi, Stefano, De Placido, Sabino, Schettini, Francesco, Pazzola, Antonio, Ponzone, Riccardo, Montemurro, Filippo, Lunardi, Gianluigi, Notaro, Rosario, De Angioletti, Maria, Turletti, Anna, Mansutti, Mauro, Puglisi, Fabio, Frassoldati, Antonio, Porpiglia, Mauro, Fabi, Alessandra, Generali, Daniele, Scognamiglio, Giovanni, Rossi, Maura, Brasó-Maristany, Fara, Prat, Aleix, Cardinali, Barbara, Piccioli, Patrizia, Serra, Martina, Lastraioli, Sonia, Bighin, Claudia, Poggio, Francesca, Lambertini, Matteo, Del Mastro, Lucia
Published in Clinical cancer research (15.12.2023)
Published in Clinical cancer research (15.12.2023)
Get full text
Journal Article
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial
Del Mastro, Lucia, Blondeaux, Eva, De Placido, Sabino, Giuliano, Mario, Forestieri, Valeria, De Laurentiis, Michelino, Gravina, Adriano, Bisagni, Giancarlo, Rimanti, Anita, Nisticò, Cecilia, Vaccaro, Angela, Cognetti, Francesco, Fabi, Alessandra, Gasparro, Simona, Garrone, Ornella, Urracci, Ylenia, Poletti, Paola, Correale, Pierpaolo, Bighin, Claudia, Puglisi, Fabio, Montemurro, Filippo, Colantuoni, Giuseppe, Lambertini, Matteo, Boni, Luca, Venturini, M, Abate, A, Pastorino, S, Canavese, G, Vecchio, C, Guenzi, M, Levaggi, A, Giraudi, S, Aitini, E, Fornari, G, Miraglia, S, Buonfanti, G, Cherchi, M.C., Vaccaro, A, Magnolfi, E, Contu, A, Labianca, R, Parisi, A, Basurto, C, Merlano, M, Russo, S, Poletto, E, Nardi, M, Grasso, D, Fontana, A, Comandè, M, Cavanna, L, Iacobelli, S, Milani, S, Mustacchi, G, Venturini, S, Scinto, A.F., Sarobba, M.G., Pugliese, P, Bernardo, A, Pavese, I, Coccaro, M, Massidda, B, Ionta, M.T., Nuzzo, A, Laudadio, L, Barduagni, M, Ciardiello, F, Tinessa, V, Ficorella, A, Moscetti, L, Vallini, I, Montedoro, M, Seles, E, Morano, F, Adamo, V, Pancotti, A, Palmisani, V, Ruggeri, A, Cammilluzzi, E, Carrozza, F, D'Aprile, M, Gallotti, P, Chiesa, E, Testore, F, D'Arco, A, Ferro, A, Jirillo, A, Pezzoli, M, Scambia, G, Iacono, C, Masullo, P, Tomasello, G, Gandini, G, Zoboli, A, Bottero, C, Cazzaniga, M, Genua, G, Palazzo, S, D'Amico, M, Perrone, D
Published in The lancet oncology (01.12.2022)
Published in The lancet oncology (01.12.2022)
Get full text
Journal Article
Nine-weeks versus one-year trastuzumab for early-stage HER2+ breast cancer: 10-year update of the Short-HER phase III randomized trial
Conte, Pier Franco, Bisagni, Giancarlo, Piacentini, Federico, Sarti, Samanta, Minichillo, Santino, Anselmi, Elisa, Aieta, Michele, Gebbia, Vittorio, Schirone, A, Musolino, Antonino, Garrone, Ornelia, Beano, A, Rimanti, Anita, Giotta, Francesco, Turletti, Anna, Dieci, Maria Vittoria, Vicini, Roberto, Balduzzi, Sara, D'Amico, R, Guarneri, Valentina
Published in Journal of clinical oncology (10.06.2023)
Published in Journal of clinical oncology (10.06.2023)
Get full text
Journal Article
Dissecting the prognostic role of baseline body mass index (BMI) in early breast cancer (BC): Individual patient-level analysis from five mammella interGruppo (MIG) and gruppo italiano mammella (GIM) randomized clinical trials (RCTs)
Soldato, Davide, Blondeaux, Eva, Bruzzone, Marco, Mura, Silvia, De Laurentiis, Michelino, Turletti, Anna, De Placido, Sabino, Bisagni, Giancarlo, Rimanti, Anita, Michelotti, Andrea, Fabi, Alessandra, Russo, Antonio, Gori, Stefania, Durando, Antonio, Nader Marta, Guilherme, de Azambuja, Evandro, Di Meglio, Antonio, Vaz-Luis, Ines, Lambertini, Matteo, Del Mastro, Lucia
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Dose‐dense adjuvant chemotherapy in HER2‐positive early breast cancer patients before and after the introduction of trastuzumab: Exploratory analysis of the GIM2 trial
Lambertini, Matteo, Poggio, Francesca, Bruzzone, Marco, Conte, Benedetta, Bighin, Claudia, Azambuja, Evandro, Giuliano, Mario, De Laurentiis, Michele, Cognetti, Francesco, Fabi, Alessandra, Bisagni, Giancarlo, Durando, Antonio, Turletti, Anna, Urracci, Ylenia, Garrone, Ornella, Puglisi, Fabio, Montemurro, Filippo, Ceppi, Marcello, Del Mastro, Lucia
Published in International journal of cancer (01.07.2020)
Published in International journal of cancer (01.07.2020)
Get full text
Journal Article
Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies
Lambertini, Matteo, Ceppi, Marcello, Cognetti, Francesco, Cavazzini, Giovanna, De Laurentiis, Michele, De Placido, Sabino, Michelotti, Andrea, Bisagni, Giancarlo, Durando, Antonio, Valle, Enrichetta, Scotto, Tiziana, De Censi, Andrea, Turletti, Anna, Benasso, Marco, Barni, Sandro, Montemurro, Filippo, Puglisi, Fabio, Levaggi, Alessia, Giraudi, Sara, Bighin, Claudia, Bruzzi, Paolo, Del Mastro, Lucia
Published in European journal of cancer (1990) (01.01.2017)
Published in European journal of cancer (1990) (01.01.2017)
Get full text
Journal Article
Abstract P3-09-03: Single nucletotide polymorphisms of aromatase gene ( CYP19A1 ) and toxicity of adjuvant aromatase inhibitors: A translational, prospective study
Conte, Benedetta, Molinelli, Chiara, Bisagni, Giancarlo, Durando, Antonio, Sanna, Giovanni, Gori, Stefania, Garrone, Ornella, Tamberi, Stefano, De Placido, Sabino, Schettini, Francesco, Pazzola, Antonio, Ponzone, Riccardo, Montemurro, Filippo, Lunardi, Gianluigi, Notaro, Rosario, Turletti, Anna, Bighin, Claudia, Poggio, Francesca, Buzzatti, Giulia, Lambertini, Matteo, Boni, Luca, Del Mastro, Lucia
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Published in Cancer research (Chicago, Ill.) (15.02.2022)
Get full text
Journal Article
Abstract P2-15-14: Triple negative (TNBC) metastatic breast cancer (MBC) patients (pts): Is chemotherapy (CHT) choice influenced by adjuvant (adj) treatments? Results from the GIM-13 AMBRA study
Mustacchi, Giorgio, Beano, Alessandra, Fabi, Alessandra, Livi, Lorenzo, Bernardo, Antonio, Riccardi, Ferdinando, Marchetti, Paolo, Garrone, Ornella, Diodati, Lucrezia, Biganzoli, Laura, Giordano, Monica, Turletti, Anna, Blasi, Livio, Milani, Andrea, Natoli, Clara, Riemma, Marta, D'Alonzo, Alessia, Arpino, Grazia, Pronzato, Paolo, Cazzaniga, Marina E
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
Abstract P5-07-10: Progression-free survival (PFS) and overall survival (OS) in HER2-ve advanced breast cancer (ABC) patients (pts) according to the molecular subtype in the era of modern agents. Results from the GIM-13 AMBRA study
Cazzaniga, Marina Elena, De Placido, Sabino, D'Alonzo, Alessia, Piezzo, Michela, Natoli, Clara, Milani, Andrea, Bologna, Alessandra, Alu, Massimiliano, Turletti, Anna, Pugliese, Palma, Biganzoli, Laura, De Angelis, Claudia, Garrone, Ornella, Marchetti, Paolo, Riccardi, Ferdinando, Bernardo, Antonio, Livi, Lorenzo, Fabi, Alessandra, Taverniti, Cristiana, Romagnoli, Emanuela, Pronzato, Paolo, Mustacchi, Giorgio
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
Nab-paclitaxel in clinical practice: Preliminary data from the mantel study
Garrone, Ornella, Saggia, Chiara, Bergnolo, Paola, Beano, Alessandra, Castiglione, Federico, Vanella, Paola, Turletti, Anna, De Conciliis, Enrico, Vellani, Giorgio, Denaro, Nerina, Bellini, Elisa, Miraglio, Emanuela, Merlano, Marco Carlo
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
First-line therapy with fulvestrant (FUL) in HR+ve, HER2-ve advanced pre-treated breast cancer (ABC) patients (pts): Results from the GIM-13 AMBRA Study
Pronzato, Paolo, Mustacchi, Giorgio, Giordano, Monica, Garrone, Ornella, Del Mastro, Lucia, Natoli, Clara, Turletti, Anna, Romagnoli, Emanuela, Bologna, Alessandra, Mocerino, Carmela, Alù, Massimiliano, De Angelis, Claudia, Aversa, Caterina, Arpino, Grazia, Taverniti, Cristiana, Biganzoli, Laura, Meattini, Icro, Piezzo, Michela, Cazzaniga, Marina Elena
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
Progression-free survival (PFS) and overall survival (OS) in HER2-ve advanced breast cancer (ABC) patients (pts) according to the molecular subtype in the era of modern agents: Results from the GIM-13 AMBRA study
Cazzaniga, Marina Elena, Pronzato, Paolo, Schettini, Francesco, Del Mastro, Lucia, Riemma, Maria, Alù, Massimiliano, Turletti, Anna, Giordano, Monica, Pugliese, Palma, De Angelis, Claudia, Garrone, Ornella, Marchetti, Paolo, Riccardi, Ferdinando, Bernardo, Antonio, Livi, Lorenzo, Fabi, Alessandra, Taverniti, Cristiana, De Placido, Sabino, Mustacchi, Giorgio
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study
Cazzaniga, Marina Elena, Pronzato, Paolo, Amoroso, Domenico, Bernardo, Antonio, Biganzoli, Laura, Bisagni, Giancarlo, Blasi, Livio, Bria, Emilio, Cognetti, Francesco, Crinò, Lucio, De Laurentiis, Michelino, Del Mastro, Lucia, De Placido, Sabino, Beano, Alessandra, Ferraù, Francesco, Foladore, Silva, Forcignanò, Rosachiara, Gamucci, Teresa, Garrone, Ornella, Gennari, Alessandra, Giordano, Monica, Giotta, Francesco, Giovanardi, Filippo, Latini, Luciano, Livi, Lorenzo, Marchetti, Paolo, Mattioli, Rodolfo, Michelotti, Andrea, Montemurro, Filippo, Putzu, Carlo, Riccardi, Ferdinando, Ricciardi, Giuseppina, Romagnoli, Emanuela, Sarobba, Giuseppina, Spazzapan, Simon, Tagliaferri, Pierosandro, Tinari, Nicola, Tonini, Giuseppe, Turletti, Anna, Verusio, Claudio, Zambelli, Alberto, Mustacchi, Giorgio
Published in Cancers (25.12.2023)
Published in Cancers (25.12.2023)
Get full text
Journal Article
Choice of treatment and adherence to international ESO-ESMO (ABC) guidelines in HR+/HER2-ve metastatic breast cancer (MBC) patients (pts)
Cazzaniga, Marina Elena, Mustacchi, Giorgio, Romagnoli, Emanuela, Montemurro, Filippo, Caporello, Paola, De Laurentiis, Michele, Riccardi, Ferdinando, Turletti, Anna, De Angelis, Claudia, Graziano, Vincenzo, Livi, Lorenzo, Del Mastro, Lucia, Beano, Alessandra, Garrone, Ornella, Biganzoli, Laura, Pronzato, Paolo, De Placido, Sabino
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
The role of taxanes in HR+ve/HER2-ve metastatic breast cancer (MBC) patients (pts) from adjuvant to metastatic setting in the clinical practice: Results from GIM13-AMBRA study
Mustacchi, Giorgio, Cazzaniga, Marina Elena, Romagnoli, Emanuela, Montemurro, Filippo, De Laurentiis, Michele, Riccardi, Ferdinando, Turletti, Anna, Beano, Alessandra, De Angelis, Claudia, Graziano, Vincenzo, Livi, Lorenzo, Del Mastro, Lucia, Biganzoli, Laura, Garrone, Ornella, De Placido, Sabino, Marchetti, Paolo, Pronzato, Paolo
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Characteristics of disease activity able to identify risk categories and probability to respond to first-line endocrine therapy (ET) in HR+ve/HER2-ve metastatic breast cancer (MBC) patients (pts): Dream or reality? Evaluation of a composite risk score in a subgroup population of the GIM 13-AMBRA study
Mustacchi, Giorgio, Cazzaniga, Marina Elena, Giordano, Monica, Garrone, Ornella, Beano, Alessandra, Del Mastro, Lucia, Livi, Lorenzo, Iezzi, Laura, Michelotti, Andrea, Turletti, Anna, Riccardi, Ferdinando, De Laurentiis, Michele, Marchetti, Paolo, Biganzoli, Laura, Montemurro, Filippo, Romagnoli, Emanuela, De Placido, Sabino, Pronzato, Paolo
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies
Lambertini, Matteo, Blondeaux, Eva, Bisagni, Giancarlo, Mura, Silvia, De Placido, Sabino, De Laurentiis, Michelino, Fabi, Alessandra, Rimanti, Anita, Michelotti, Andrea, Mansutti, Mauro, Russo, Antonio, Montemurro, Filippo, Frassoldati, Antonio, Durando, Antonio, Gori, Stefania, Turletti, Anna, Tamberi, Stefano, Urracci, Ylenia, Fregatti, Piero, Razeti, Maria Grazia, Caputo, Roberta, De Angelis, Carmine, Sanna, Valeria, Gasparini, Elisa, Agostinetto, Elisa, de Azambuja, Evandro, Poggio, Francesca, Boni, Luca, Del Mastro, Lucia
Published in EClinicalMedicine (01.05.2023)
Published in EClinicalMedicine (01.05.2023)
Get full text
Journal Article